These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 11923701)

  • 41. Induction immunosuppression with thymoglobulin and rituximab in intestinal and multivisceral transplantation.
    Vianna RM; Mangus RS; Fridell JA; Weigman S; Kazimi M; Tector J
    Transplantation; 2008 May; 85(9):1290-3. PubMed ID: 18475186
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence of graft rejection in small bowel transplanted pigs after immunosuppression withdrawal.
    Viganó J; Abbiati F; Alessiani M; Bonfichi M; Zonta S; Bardone M; Zitelli E; Cobianchi L; Doni M; Lovisetto F; Dominioni T; De Martino M; Lusona B; Arbustini E; Dionigi P
    Transplant Proc; 2006; 38(6):1818-20. PubMed ID: 16908291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Living-related intestinal transplantation: first report of a standardized surgical technique.
    Gruessner RW; Sharp HL
    Transplantation; 1997 Dec; 64(11):1605-7. PubMed ID: 9415566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preliminary experience with alemtuzumab induction therapy combined with maintenance low-dose tacrolimus monotherapy in small-bowel transplantation in China.
    Yuan-Xin L; Ning L; You-Sheng L; Xiao-Dong N; Ming L; Jian W; Jie-Shou L
    Transplant Proc; 2010; 42(1):29-34. PubMed ID: 20172275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation.
    Sarwal MM; Yorgin PD; Alexander S; Millan MT; Belson A; Belanger N; Granucci L; Major C; Costaglio C; Sanchez J; Orlandi P; Salvatierra O
    Transplantation; 2001 Jul; 72(1):13-21. PubMed ID: 11468528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).
    Cai J
    Clin Transpl; 2009; ():83-101. PubMed ID: 20524278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early Use of Everolimus as a Third Immunosuppressive Agent for Intestinal Transplantation: A Report of 2 Cases.
    Ueno T; Toyama C; Deguchi K; Masahata K; Nomura M; Watanabe M; Kamiyama M; Tazuke Y; Bessho K; Okuyama H
    Transplant Proc; 2022 Mar; 54(2):472-475. PubMed ID: 35153057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Preliminary experience with Campath 1H induction combined with low-dose monotherapy of tacrolimus in small bowel transplantation].
    Li YX; Li N; Ni XD; Li YS; Li M; Shen J; Li JS
    Zhonghua Wai Ke Za Zhi; 2009 Jun; 47(11):810-3. PubMed ID: 19961008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients.
    Birkeland SA
    Transplantation; 2001 Apr; 71(8):1089-90. PubMed ID: 11374407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Steroid avoidance immunosuppression in low-risk kidney transplant recipients.
    Heilman RL; Mazur MJ; Reddy KS; Moss A; Post D; Mulligan D
    Transplant Proc; 2005 May; 37(4):1785-8. PubMed ID: 15919466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recipient preconditioning and donor-specific bone marrow infusion in a pig model of total bowel transplantation.
    Gruessner RW; Uckun FM; Pirenne J; Nakhleh RE; Benedetti E; Bekersky I; Troppmann C; Gruessner AC
    Transplantation; 1997 Jan; 63(1):12-20. PubMed ID: 9000654
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation.
    Gruessner RW; Burke GW; Stratta R; Sollinger H; Benedetti E; Marsh C; Stock P; Boudreaux JP; Martin M; Drangstveit MB; Sutherland DE; Gruessner A
    Transplantation; 1996 Jan; 61(2):261-73. PubMed ID: 8600635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months.
    Ramirez CB; Doria C; di Francesco F; Iaria M; Kang Y; Marino IR
    J Surg Res; 2007 Apr; 138(2):198-204. PubMed ID: 17292404
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.
    Cacciarelli TV; Green M; Jaffe R; Mazariegos GV; Jain A; Fung JJ; Reyes J
    Transplantation; 1998 Oct; 66(8):1047-52. PubMed ID: 9808490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Small bowel transplantation using grafts from living-related donors. Two case reports.
    Fujimoto Y; Uemoto S; Inomata Y; Egawa H; Fujita S; Kawanami T; Tsuruyama T; Hayashi M; Kiuchi T; Asonuma K; Tanaka K
    Transpl Int; 2000; 13 Suppl 1():S179-84. PubMed ID: 11111992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation.
    Vincenti F; Ramos E; Brattstrom C; Cho S; Ekberg H; Grinyo J; Johnson R; Kuypers D; Stuart F; Khanna A; Navarro M; Nashan B
    Transplantation; 2001 May; 71(9):1282-7. PubMed ID: 11397963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical intestinal transplantation: new perspectives and immunologic considerations.
    Abu-Elmagd K; Reyes J; Todo S; Rao A; Lee R; Irish W; Furukawa H; Bueno J; McMichael J; Fawzy AT; Murase N; Demetris J; Rakela J; Fung JJ; Starzl TE
    J Am Coll Surg; 1998 May; 186(5):512-25; discussion 525-7. PubMed ID: 9583691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
    Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M
    Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
    Foster RD; Pham S; Li S; Aitouche A
    Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Daclizumab induction therapy associated with tacrolimus-MMF has better outcome compared with tacrolimus-MMF alone in pediatric living donor liver transplantation.
    Schuller S; Wiederkehr JC; Coelho-Lemos IM; Avilla SG; Schultz C
    Transplant Proc; 2005 Mar; 37(2):1151-2. PubMed ID: 15848653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.